Advertisement
Advertisement
PTCT
PTC Therapeutics, Inc.
71.06
USDSponsored
+1.24
+1.78%
Aug 24, 16:00 UTC -4
Closed
After-Market
71.07
+0.01
+0.01%
PTC Therapeutics, Inc. Profile
About
Info & Links
CEO
Matthew B. Klein
Headquarters
WARREN, NJ 07059, UNITED STATES
Industry
Sector
Website
Auditor
Ernst & Young LLP
Share holders
73
Employees
991
PTC Therapeutics, Inc. Statistics
Valuation Measures
Market Capitalization2
5.93B
Enterprise Value
7.80B
Enterprise Value/EBITDA(ttm)
47.92
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
5.78
Price to Book(mrq)
--
Price to Cash(ytd)
7.96
Profitability
Gross Margin(ttm)
93.12%
Operating Margin(ttm)
-3.80%
Profit Margin(ttm)
-13.07%
Return on Equity(ttm)
-362.45%
Return on Invested Capital(ttm)
-3.10%
Return on Assets(ttm)
-1.32%
Income Statement
Revenue(ttm)
1.01B
Revenue Per Share(ttm)
12.09
Gross Profit(ttm)
938.07M
EBITDA(ttm)3
162.79M
Net Income Available to Common(ttm)
-38.38M
Diluted EPS(ttm)
-0.58
Share Statistics
Beta (5Y Monthly)
0.56
52-Week Change
40.52%
S&P 500 52-Week Change
18.66%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
83.46M
Dividend Yield
0.00%
Float4
79.04M
% Held by Insiders
5.30%
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
2.23B
Total Cash Per Share(mrq)
26.71
Total Debt(mrq)
2.92B
Total Debt/Equity(mrq)
-1764.85%
Current Ratio(mrq)
3.39%
Quick Ratio(mrq)
3.28%
Book Value Per Share(mrq)
-1.98
Cash Flow
Operating Cash Flow Per Share(ytd)
0.76
Free Cash Flow(ytd)
66.68M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement